Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced its operating results for the third quarter and nine months ended September 30, 2013. Revenue and other income for the third quarter of 2013 was approximately $89,000, including $58,000 in sales of...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it is scheduled to report financial results for its third quarter ended September...
Guided Therapeutics, Inc., (OTCBB: GTHP) (OTCQB: GTHP), today announced that it received a $250,000 milestone payment from Freedom Meditech, Inc., a San Diego, California based ophthalmic medical device company. The payment was received as part of an agreement under...
Guided Therapeutics, Inc., (OTCBB: GTHP) (OTCQB: GTHP), today announced that it has commenced an exchange offer for certain of its outstanding warrants to purchase up to an aggregate of approximately 3.6 million shares of its common stock. The warrants eligible for...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced the signing of additional distributors for the LuViva® Advanced Cervical Scan in territories that include France, Qatar, Malaysia, Indonesia and Bangladesh. Combined, these territories include...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that the company received additional questions from the U.S. Food and Drug Administration (FDA) regarding the pre-market approval application for the LuViva® Advanced Cervical Scan. FDA advised the...
